LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Long Term Provisions History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹0.47 Cr | ₹0.61 Cr | ₹0.63 Cr | ₹0.59 Cr | ₹0.46 Cr |
What is the latest Long Term Provisions ratio of LASA SUPERGENERICS ?
| Year | Long Term Provisions |
|---|---|
| Mar2024 | ₹0.47 Cr |
| Mar2023 | ₹0.61 Cr |
| Mar2022 | ₹0.63 Cr |
| Mar2021 | ₹0.59 Cr |
| Mar2020 | ₹0.46 Cr |
How is Long Term Provisions of LASA SUPERGENERICS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.47 Cr | -21.78 | |
| Mar2023 | ₹0.61 Cr | -3.19 | |
| Mar2022 | ₹0.63 Cr | 6.83 | |
| Mar2021 | ₹0.59 Cr | 26.84 | |
| Mar2020 | ₹0.46 Cr | - | |
Compare Long Term Provisions of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹37.6 Cr | 20.2% | -5.8% | -60.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 20.2% |
-5.8% |
-60.2% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses